医薬品検査機市場 – 2029年までの世界予測

Pharmaceutical Inspection Machines Market - Global Forecast to 2029

医薬品検査機市場 - コンポーネント[(画像検査、X線、重量チェッカー、金属検出器)、ソフトウェア]、タイプ(手動、自動)、包装タイプ(シリンジ、ブリスター、ボトル)、製剤(非経口、経口)、市場規模、シェアおよび動向 - 2029年までの世界予測
Pharmaceutical Inspection Machines Market Size, Share & Trends by Component ((Vision Inspection, X-Ray, Checkweigher, Metal Detector), Software), Type (Manual, Automatic), Packaging Type (Syringe, Blister, Bottle), Formulation (Parenteral, Oral) - Global Forecast to 2029
出版年月2024年7月
ページ数420
図表数516
価格タイプシングルユーザライセンス
価格USD 4,950
種別英文調査報告書

Report Overview

The pharmaceutical inspection machines market is projected to reach USD 1.4 billion by 2029 from USD 0.9 billion in 2024, at a CAGR of 7.6% during the forecast period.

医薬品検査機市場は、予測期間中のCAGR 7.6%で、2024年の9億ドルから2029年までに14億ドルに達すると予測されています。

医薬品検査機市場 - 2029年までの世界予測

“The Vision Inspection System segment holds dominant share in the pharmaceutical inspection machines market.”

Based on the component, the pharmaceutical inspection machines market is divided into inspection systems and software. The inspection systems is further segmented into vision inspection systems, X-ray inspection systems, leak detection systems, metal detectors, combination systems, checkweighers, and other inspection systems. The vision inspection systems dominated the segment owing to various factors such as increasing demand for high-speed and accurate defect detection in pharmaceutical manufacturing and launch of technologically advanced vision inspection systems with AI & machine learning.

“Syringes pharmaceutical inspection machines market is likely to grow at faster pace.”

Based on the packaging type, the pharmaceutical inspection machines market is divided into syringes, blister, ampoules & vials, bottles, and other packaging types. Syringe segment in the pharmaceutical inspection machines market grows at a faster pace in 2023. The significant growth of syringe segment in the packaging type segment is due to increasing adoption of inspection machinery for assessing pre-filled syringes, focus on ensuring product integrity and minimizing risks associated with contamination or defects, and advancements in inspection technology, such as enhanced capabilities in detecting minute abnormalities or ensuring proper labeling.

医薬品検査機市場 - 2029年までの世界予測 ecosystem

“The fully automated inspection machines dominated the type segments.”

Based on type, the pharmaceutical inspection machines market is segmented into, semi-automated inspection systems, manual systems, and fully automated inspection systems. The fully automated inspection systems dominated the type segment however semi-automated inspection systems is anticipated to grow at significant CAGR during the forecast period. Factors like increased detection rates, enhanced throughput rates and precise inspection capabilities for the fully automated systems are likely to drive the segmental growth.

“CROs & CDMOs segment is likely to grow at significant CAGR during the forecast period”

Based on end user, the pharmaceutical inspection machines market is segmented into, pharmaceutical companies, biotechnology companies and CROs & CDMOs. The pharmaceutical company segment dominated the pharmaceutical inspection machines market. CROs & CDMOs segment is anticipated to grow at significant CAGR during the forecast period owing to increased outsourcing of pharmaceutical productions and rise in number of CDMOs across the emerging markets.

“Asia Pacific region estimated to show fastest growth rate.”

Geographically, the pharmaceutical inspection machines market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. In 2023, North America accounted for the major share of the pharmaceutical inspection machines market. The Asia Pacific region is likely to grow at significant CAGR during the forecast period owing to various factors such as rising production of generic drugs and the rapid expansion of pharmaceutical and biotechnology sectors in the region. Furthermore, rise in outsourcing trends, and increased focus on quality control is likely drive market expansion in the region.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 70%, and Demand Side – 30%
  • By Designation (Supply Side): Managers – 45%, CXOs & Directors – 30%, Executives- 25%
  • By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, MEA- 5%

医薬品検査機市場 - 2029年までの世界予測 region

List of Companies Profiled in the Report:

  • Körber AG (Germany)
  • Mettler-Toledo (Switzerland)
  • Omron Corporation (Japan)
  • Cognex corporation (US)
  • Stevanato Group (Italy)
  • Antares Vision S.P.A (Italy)
  • Syntegon Technology GmbH (Germany)
  • Optel Group (Canada)
  • Jekson Vision (India),
  • ACG (India)
  • Brevetti CEA SPA (Italy)
  • Roquette Frères (France)
  • Tofflon Life Science(China)
  • Proditec (France)
  • Wipotec Gmbh (Germany)
  • CMP Pharma S.R.L (Italy)
  • Keyence Corporation (Japan),
  • Cassel Messentechnik Gmbh (Germany)
  • Thermo Fisher Scientific Inc (US)
  • Loma Systems (UK),
  • Vitronic Dr.-Ing. Stein Bildverarbeitungssysteme GmbH (Germany)
  • Minebea Intec Gmbh (Germany)
  • Marchesini Group S.p.A. (Italy)
  • N.K.P pharma Pvt Ltd (India)
  • Span systems (India)

Research Coverage:

This report provides a detailed picture of the pharmaceutical inspection machines market. It aims at estimating the size and future growth potential of the market across different segments such as components, type, packaging type, formulation, end user, and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key Drivers (Increasing use of pharmaceutical inspection machines by pharmaceutical and biotechnology companies, Increasing number of inspection checkpoint mandates, Increasing product recall), restraints (High Initial Investment, Data Security and Privacy Concerns) opportunities (Rising outsourcing of manufacturing operations to emerging economies, Advancement in technologies such as IoT, machine learning, and artificial intelligence), and challenges (Complexities in integrating pharmaceutical inspection machines) influencing the growth of the market.
  • Product Development/Innovation: Detailed insights on newly launched products and technological assessment of the pharmaceutical inspection machines market.
  • Market Development: Comprehensive information about lucrative markets the report analyses the market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the pharmaceutical inspection machines market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and products offerings of leading players like Körber AG (Germany), Mettler-Toledo  (Switzerland), Omron Corporation (Japan), Cognex corporation (US), Stevanato Group (Italy), Antares Vision S.P.A (Italy), Syntegon Technology GmbH (Germany), Optel Group (Canada), Jekson Vision (India), ACG (India), Brevetti CEA SPA (Italy), Roquette Frères (France), Tofflon Life Science (China), Proditec (France), Wipotec Gmbh (Germany) CMP Pharma S.R.L (Italy), Keyence Corporation (Japan), Cassel Messentechnik Gmbh (Germany), Thermo Fisher Scientific Inc (US), Loma Systems (UK), Vitronic Dr.-Ing. Stein Bildverarbeitungssysteme GmbH (Germany), Minebea Intec Gmbh (Germany), Marchesini Group S.p.A. (Italy), N.K.P pharma Pvt Ltd (India) and Span systems (India).

Table of Contents

1            INTRODUCTION            35

1.1         STUDY OBJECTIVES      35

1.2         MARKET DEFINITION   35

1.3         INCLUSIONS & EXCLUSIONS     36

1.4         STUDY SCOPE  37

1.4.1      SEGMENTS COVERED   37

1.4.2      REGIONS COVERED      38

1.4.3      YEARS CONSIDERED     38

1.4.4      CURRENCY CONSIDERED          39

1.5         STAKEHOLDERS            39

1.6         SUMMARY OF CHANGES            39

1.6.1      RECESSION IMPACT      40

2            RESEARCH METHODOLOGY     41

2.1         RESEARCH DATA           41

2.1.1      SECONDARY DATA       42

2.1.1.1   Objectives of secondary research     42

2.1.2      PRIMARY DATA 43

2.1.2.1   Objectives of primary research         43

2.1.2.2   Breakdown of primaries     43

2.2         MARKET SIZE ESTIMATION       44

2.2.1      INSIGHTS FROM PRIMARY EXPERTS      47

2.2.2      SEGMENTAL MARKET SIZE ESTIMATION           48

2.3         GROWTH RATE ASSUMPTIONS 49

2.4         STUDY ASSUMPTIONS  51

2.5         MARKET BREAKDOWN & DATA TRIANGULATION          52

2.6         RISK ANALYSIS 52

2.7         RESEARCH LIMITATIONS           53

2.8         IMPACT OF ECONOMIC RECESSION ON PHARMACEUTICAL INSPECTION MACHINES MARKET          53

3            EXECUTIVE SUMMARY 55

4            PREMIUM INSIGHTS      61

4.1         PHARMACEUTICAL INSPECTION MACHINES MARKET OVERVIEW              61

4.2         NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY PACKAGING TYPE AND COUNTRY (2023)     62

4.3         PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2024 VS. 2029       63

4.4         PHARMACEUTICAL INSPECTION MACHINES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES       64

5            MARKET OVERVIEW     65

5.1         INTRODUCTION            65

5.2         MARKET DYNAMICS     65

5.2.1      DRIVERS            66

5.2.1.1   Increasing use of inspection machines by pharmaceutical and biotechnology companies           66

5.2.1.2   Rising number of inspection checkpoint mandates       66

5.2.1.3   Technological advancements and stringent regulatory mandates for high-quality products 67

5.2.2      RESTRAINTS     68

5.2.2.1   High initial capital expenditure and recurring maintenance costs             68

5.2.2.2   Increased data security and privacy concerns 68

5.2.3      OPPORTUNITIES           69

5.2.3.1   Increasing outsourcing of manufacturing operations to emerging economies              69

5.2.3.2   Focus on production optimization and high R&D investments   70

5.2.4      CHALLENGES   71

5.2.4.1   Complexities in integrating pharmaceutical inspection machines             71

5.3         TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 72

5.4         TECHNOLOGY ANALYSIS           72

5.4.1      KEY TECHNOLOGIES    72

5.4.1.1   Machine vision technology 72

5.4.1.2   X-ray inspection technology             73

5.4.1.3   Laser inspection technology             73

5.4.2      COMPLEMENTARY TECHNOLOGIES     73

5.4.2.1   Advanced sensors and imaging techniques     73

5.4.2.2   Robotics and automation   73

5.4.2.3   Artificial intelligence          74

5.5         PRICING ANALYSIS        74

5.5.1      AVERAGE PRICING ANALYSIS FOR INSPECTION MACHINES, BY COMPONENT   75

5.5.2      AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL INSPECTION MACHINES, BY REGION 76

5.6         VALUE CHAIN ANALYSIS            77

5.7         SUPPLY CHAIN ANALYSIS          78

5.7.1      ROLE IN SUPPLY CHAIN             79

5.8         ECOSYSTEM ANALYSIS 81

5.8.1      PHARMACEUTICAL INSPECTION MACHINE SUPPLIERS 82

5.8.2      END USERS       82

5.8.3      REGULATORY BODIES  83

5.9         PATENT ANALYSIS        83

5.9.1      METHODOLOGY           83

5.9.2      NUMBER OF PATENTS APPLIED AND GRANTED, BY DOCUMENT TYPE,

2014–2024          84

5.9.3      INNOVATION AND PATENT APPLICATION        84

5.9.4      TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS 85

5.10       TRADE ANALYSIS          88

5.10.1    IMPORT DATA FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING OR CHECKING (HS CODE: 903180) 88

5.10.2    EXPORT DATA FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING OR CHECKING (HS CODE: 903180) 89

5.10.3    IMPORT DATA FOR PARTS AND ACCESSORIES FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING AND CHECKING

(HS CODE: 903190)         89

5.10.4    EXPORT DATA FOR PARTS AND ACCESSORIES FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING AND CHECKING

(HS CODE: 903190)         90

5.11       KEY CONFERENCES AND EVENTS, 2024–2025     90

5.12       REGULATORY LANDSCAPE       91

5.12.1    CDRH REGULATIONS ON PHARMACEUTICAL INSPECTION MACHINES              91

5.12.2    LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND

OTHER ORGANIZATIONS          92

5.12.2.1 North America: List of regulatory bodies, government agencies, and other organizations       92

5.12.2.2 Europe: List of regulatory bodies, government agencies, and other organizations              93

5.12.2.3 Asia Pacific: List of regulatory bodies, government agencies, and other organizations       94

5.12.2.4 Rest of the World: List of regulatory bodies, government agencies, and other organizations       95

5.13       INVESTMENT AND FUNDING SCENARIO            96

5.14       PORTER’S FIVE FORCES ANALYSIS         97

5.14.1    THREAT OF NEW ENTRANTS    98

5.14.2    THREAT OF SUBSTITUTES         98

5.14.3    BARGAINING POWER OF BUYERS           98

5.14.4    BARGAINING POWER OF SUPPLIERS     98

5.14.5    INTENSITY OF COMPETITIVE RIVALRY 98

5.15       KEY STAKEHOLDERS AND BUYING CRITERIA    99

5.15.1    KEY STAKEHOLDERS    99

5.15.2    KEY BUYING CRITERIA 100

6            PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT   103

6.1         INTRODUCTION            104

6.2         PHARMACEUTICAL INSPECTION SYSTEMS        104

6.2.1      VISION INSPECTION SYSTEMS  108

6.2.1.1   Multifunctional vision inspection systems      113

6.2.1.1.1 Versatility and improved production efficiency to drive segment 113

6.2.1.2   Specialized vision inspection systems             116

6.2.1.2.1 Stringent quality standards and better patient well-being to propel segment growth   116

6.2.2      X-RAY INSPECTION SYSTEMS    119

6.2.2.1   Increasing demand for precise underfill and overfill inspection to aid market growth   119

6.2.3      LEAK DETECTION SYSTEMS      123

6.2.3.1   Rising adoption in pharmaceutical applications to drive market growth    123

6.2.4      METAL DETECTORS     127

6.2.4.1   Growing need for metal contaminant detection in food & beverage industry to boost demand      127

6.2.5      CHECKWEIGHERS         131

6.2.5.1   Increased focus on reducing waste in manufacturing process to aid market growth              131

6.2.6      COMBINATION SYSTEMS           135

6.2.6.1   Technological advancements for ensuring thorough quality assessment and regulatory compliance to drive market           135

6.2.7      OTHER PHARMACEUTICAL INSPECTION SYSTEMS        139

6.3         PHARMACEUTICAL INSPECTION SOFTWARE    142

6.3.1      RISING NEED TO IMPROVE INSPECTION EFFICIENCY TO PROPEL ADOPTION       142

7            PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE              147

7.1         INTRODUCTION            148

7.2         FULLY AUTOMATED PHARMACEUTICAL INSPECTION MACHINES              148

7.2.1      SUPERIOR THROUGHPUT RATES AND DEFECT DETECTION ACCURACY IN HIGH-VISCOSITY SUSPENSIONS TO DRIVE MARKET        148

7.3         SEMI-AUTOMATED PHARMACEUTICAL INSPECTION MACHINES              152

7.3.1      SIMULTANEOUS INSPECTION CAPABILITIES WITH HIGH STANDARDS OF PHARMACEUTICAL QUALITY CONTROL TO AID MARKET GROWTH 152

7.4         MANUAL PHARMACEUTICAL INSPECTION MACHINES  156

7.4.1      COST-EFFECTIVENESS TO AUGMENT SEGMENT GROWTH        156

8            PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE    160

8.1         INTRODUCTION            161

8.2         AMPOULES & VIALS      161

8.2.1      INCREASING DEMAND FOR VACCINES AND BIOPHARMACEUTICALS TO FUEL MARKET GROWTH     161

8.3         SYRINGES          165

8.3.1      IMPROVED SAFETY AND INCREASED COMPLIANCE WITH CGMP STANDARDS TO SUPPORT MARKET GROWTH  165

8.4         BOTTLES           168

8.4.1      RISING DEMAND FOR LIQUID OR SOLID RESIDUE DETECTION TO AUGMENT MARKET GROWTH  168

8.5         BLISTERS           171

8.5.1      SUPERIOR PRODUCT PROTECTION AND ENHANCED PATIENT COMPLIANCE TO BOOST MARKET GROWTH    171

8.6         OTHER PACKAGING TYPES       174

9            PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION 178

9.1         INTRODUCTION            179

9.2         ORAL FORMULATIONS 179

9.2.1      TABLETS & CAPSULES  183

9.2.1.1   Increasing applications in pharmaceutical industry to drive segment        183

9.2.2      ORAL SOLUTIONS & SUSPENSIONS/SYRUPS      186

9.2.2.1   Focus on improved product quality and prevention of contamination to fuel segment growth   186

9.2.3      OTHER ORAL FORMULATIONS 189

9.3         PARENTERAL FORMULATIONS 192

9.3.1      INCREASED PRODUCTION THROUGHPUT AND REDUCED HUMAN ERRORS TO BOOST SEGMENT GROWTH            192

9.4         OTHER FORMULATIONS            196

10          PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER              200

10.1       INTRODUCTION            201

10.2       PHARMACEUTICAL COMPANIES            201

10.2.1    HIGH PREVALENCE OF CHRONIC DISEASES TO SUPPORT MARKET GROWTH          201

10.3       BIOTECHNOLOGY COMPANIES 205

10.3.1    FOCUS ON REDUCING COUNTERFEIT DRUG PRODUCTION AND IMPROVING PRODUCT QUALITY TO SPUR MARKET GROWTH  205

10.4       CROS & CDMOS              208

10.4.1    LOW MANUFACTURING COSTS AND HIGH-QUALITY MAINTENANCE TO FUEL MARKET GROWTH     208

11          PHARMACEUTICAL INSPECTION MACHINES MARKET, BY REGION              213

11.1       INTRODUCTION            214

11.2       NORTH AMERICA          215

11.2.1    US         221

11.2.1.1 US to dominate North American pharmaceutical inspection machines market during forecast period        221

11.2.2    CANADA            225

11.2.2.1 Focus on better healthcare quality and increased patient safety to support market growth   225

11.2.3    NORTH AMERICA: RECESSION IMPACT 230

11.3       EUROPE             231

11.3.1    GERMANY         235

11.3.1.1 High healthcare spending and presence of key pharmaceutical manufacturers to aid market growth              235

11.3.2    UK         240

11.3.2.1 Rising demand for personalized medicines and increasing geriatric population to augment market growth     240

11.3.3    FRANCE             244

11.3.3.1 Growth in generic drug market and increased pharmaceutical exports to spur adoption 244

11.3.4    ITALY   249

11.3.4.1 Favorable government initiatives and increased private investments to drive market   249

11.3.5    SPAIN   253

11.3.5.1 Improved healthcare infrastructure and high prevalence of chronic diseases to boost market growth          253

11.3.6    REST OF EUROPE           258

11.3.7    EUROPE: RECESSION IMPACT   262

11.4       ASIA PACIFIC    263

11.4.1    CHINA  269

11.4.1.1 Increased investment in healthcare infrastructure to propel market growth              269

11.4.2    JAPAN  273

11.4.2.1 Well-developed pharmaceutical manufacturing industry and stringent healthcare regulations to drive market 273

11.4.3    INDIA   278

11.4.3.1 Growing focus on cost-effective branded drug production to fuel market growth              278

11.4.4    AUSTRALIA       282

11.4.4.1 High R&D expenditure and technological advancements to fuel market growth              282

11.4.5    SOUTH KOREA 286

11.4.5.1 Attractive medical tourism industry and favorable government policies to propel market growth     286

11.4.6    REST OF ASIA PACIFIC  291

11.4.7    ASIA PACIFIC: RECESSION IMPACT        295

11.5       LATIN AMERICA             296

11.5.1    BRAZIL 301

11.5.1.1 Increasing geriatric population and rising per capita income to aid market growth              301

11.5.2    MEXICO             305

11.5.2.1 Improving healthcare infrastructure and burgeoning pharmaceutical industry to augment market growth     305

11.5.3    REST OF LATIN AMERICA          309

11.5.4    LATIN AMERICA: RECESSION IMPACT   313

11.6       MIDDLE EAST & AFRICA             314

11.6.1    GCC COUNTRIES           318

11.6.1.1 Robust economic growth and high public healthcare spending to support market growth   318

11.6.2    REST OF MIDDLE EAST & AFRICA           322

11.6.3    MIDDLE EAST & AFRICA: RECESSION IMPACT   326

12          COMPETITIVE LANDSCAPE       327

12.1       INTRODUCTION            327

12.2       KEY PLAYER STRATEGY/RIGHT TO WIN             327

12.2.1    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PHARMACEUTICAL INSPECTION MACHINES MARKET  327

12.3       REVENUE ANALYSIS      329

12.4       MARKET SHARE ANALYSIS         330

12.5       COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023   332

12.5.1    STARS  332

12.5.2    EMERGING LEADERS    332

12.5.3    PERVASIVE PLAYERS     332

12.5.4    PARTICIPANTS 332

12.5.5    COMPANY FOOTPRINT: KEY PLAYERS, 2023      334

12.5.5.1 Company footprint            334

12.5.5.2 Component footprint         335

12.5.5.3 Type footprint     336

12.5.5.4 Packaging type footprint    337

12.5.5.5 Region footprint  338

12.6       COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023          339

12.6.1    PROGRESSIVE COMPANIES       339

12.6.2    RESPONSIVE COMPANIES          339

12.6.3    DYNAMIC COMPANIES 339

12.6.4    STARTING BLOCKS       339

12.6.5    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023             341

12.7       VALUATION & FINANCIAL METRICS      342

12.8       BRAND/PRODUCT COMPARISON          344

12.9       COMPETITIVE SCENARIO          345

12.9.1    PRODUCT LAUNCHES  345

12.9.2    DEALS  346

12.9.3    EXPANSIONS    347

13          COMPANY PROFILES    348

13.1       KEY PLAYERS   348

13.1.1    KÖRBER AG       348

13.1.1.1 Business overview 348

13.1.1.2 Products/Services/Solutions offered 349

13.1.1.3 Recent developments         352

13.1.1.3.1            Deals     352

13.1.1.4 MnM view           352

13.1.1.4.1            Key strengths       352

13.1.1.4.2            Strategic choices  352

13.1.1.4.3            Weaknesses & competitive threats   352

13.1.2    METTLER TOLEDO       353

13.1.2.1 Business overview 353

13.1.2.2 Products/Services/Solutions offered 354

13.1.2.3 Recent developments         358

13.1.2.3.1            Product launches 358

13.1.2.3.2            Expansions          359

13.1.2.4 MnM view           359

13.1.2.4.1            Key strengths       359

13.1.2.4.2            Strategic choices  359

13.1.2.4.3            Weaknesses & competitive threats   359

13.1.3    OMRON CORPORATION             360

13.1.3.1 Business overview 360

13.1.3.2 Products/Services/Solutions offered 361

13.1.3.3 MnM view           362

13.1.3.3.1            Key strengths       362

13.1.3.3.2            Strategic choices  362

13.1.3.3.3            Weaknesses & competitive threats   362

13.1.4    COGNEX CORPORATION           363

13.1.4.1 Business overview 363

13.1.4.2 Products/Services/Solutions offered 364

13.1.4.3 Recent developments         367

13.1.4.3.1            Product launches 367

13.1.4.3.2            Deals     367

13.1.4.4 MnM view           368

13.1.4.4.1            Key strengths       368

13.1.4.4.2            Strategic choices  368

13.1.4.4.3            Weaknesses & competitive threats   368

13.1.5    STEVANATO GROUP     369

13.1.5.1 Business overview 369

13.1.5.2 Products/Services/Solutions offered 370

13.1.5.3 Recent developments         372

13.1.5.3.1            Product launches 372

13.1.5.4 MnM view           372

13.1.5.4.1            Key strengths       372

13.1.5.4.2            Strategic choices  372

13.1.5.4.3            Weaknesses & competitive threats   372

13.1.6    ANTARES VISION S.P.A 373

13.1.6.1 Business overview 373

13.1.6.2 Products/Services/Solutions offered 374

13.1.6.3 Recent developments         377

13.1.6.3.1            Deals     377

13.1.7    OPTEL GROUP 378

13.1.7.1 Business overview 378

13.1.7.2 Products/Services/Solutions offered 378

13.1.8    SYNTEGON TECHNOLOGY GMBH         380

13.1.8.1 Business overview 380

13.1.8.2 Products/Services/Solutions offered 381

13.1.8.3 Recent developments         383

13.1.8.3.1            Product launches 383

13.1.9    JEKSON VISION 384

13.1.9.1 Business overview 384

13.1.9.2 Products/Services/Solutions offered 384

13.1.10  ACG      386

13.1.10.1             Business overview 386

13.1.10.2             Products/Services/Solutions offered 386

13.1.11  BREVETTI CEA SPA        389

13.1.11.1             Business overview 389

13.1.11.2             Products/Services/Solutions offered 389

13.1.11.3             Recent developments         392

13.1.11.3.1          Deals     392

13.1.12  ROQUETTE FRÈRES      393

13.1.12.1             Business overview 393

13.1.12.2             Products/Services/Solutions offered 393

13.1.13  TOFFLON LIFE SCIENCE            395

13.1.13.1             Business overview 395

13.1.13.2             Products/Services/Solutions offered 395

13.1.14  PRODITEC        397

13.1.14.1             Business overview 397

13.1.14.2             Products/Services/Solutions offered 397

13.1.15  WIPOTEC GMBH            399

13.1.15.1             Business overview 399

13.1.15.2             Products/Services/Solutions offered 399

13.1.16  CMP PHARMA S.R.L.      401

13.1.16.1             Business overview 401

13.1.16.2             Products/Services/Solutions offered 401

13.1.16.3             Recent developments         403

13.1.16.3.1          Expansions          403

13.2       OTHER PLAYERS           404

13.2.1    KEYENCE CORPORATION          404

13.2.2    CASSEL MESSTECHNIK GMBH  405

13.2.3    THERMO FISHER SCIENTIFIC INC.          406

13.2.4    LOMA SYSTEMS             407

13.2.5    VITRONIC DR.-ING. STEIN BILDVERARBEITUNGSSYSTEME GMBH              408

13.2.6    MINEBEA INTEC GMBH 409

13.2.7    MARCHESINI GROUP S.P.A.        410

13.2.8    N.K.P. PHARMA PVT. LTD.         411

13.2.9    SPAN SYSTEMS 411

14          APPENDIX         412

14.1       DISCUSSION GUIDE      412

14.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL             416

14.3       CUSTOMIZATION OPTIONS      418

14.4       RELATED REPORTS       418

14.5       AUTHOR DETAILS         419

LIST OF TABLES

TABLE 1             PHARMACEUTICAL INSPECTION MACHINES MARKET: INCLUSIONS & EXCLUSIONS     36

TABLE 2             IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS              50

TABLE 3             AVERAGE PRICING ANALYSIS FOR INSPECTION MACHINES, BY COMPONENT, 2021–2023            75

TABLE 4             PHARMACEUTICAL INSPECTION MACHINES MARKET: ROLE IN SUPPLY CHAIN          80

TABLE 5             PHARMACEUTICAL INSPECTION MACHINE SUPPLIERS: ROLE IN ECOSYSTEM 82

TABLE 6             END USERS: ROLE IN ECOSYSTEM         82

TABLE 7             REGULATORY BODIES: ROLE IN ECOSYSTEM    83

TABLE 8             NUMBER OF PATENTS APPLIED AND GRANTED, 2014–2024              84

TABLE 9             PHARMACEUTICAL INSPECTION MACHINES MARKET: TOP 12 PATENT OWNERS

IN US, 2014–2024             86

TABLE 10           KEY PATENTS IN PHARMACEUTICAL INSPECTION MACHINES MARKET (2023) 86

TABLE 11           IMPORT VOLUME FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING OR CHECKING (HS CODE: 903180), 2019–2023 (TONS) 88

TABLE 12           EXPORT VOLUME FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING OR CHECKING (HS CODE: 903180), 2019–2023 (TONS) 89

TABLE 13           IMPORT VOLUME FOR PARTS AND ACCESSORIES FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING AND CHECKING

(HS CODE: 903190), 2019–2023 (USD)      89

TABLE 14           EXPORT VOLUME FOR PARTS AND ACCESSORIES FOR INSTRUMENTS, APPLIANCES, AND MACHINES FOR MEASURING AND CHECKING

(HS CODE-903190), 2019–2023 (USD)       90

TABLE 15           PHARMACEUTICAL INSPECTION MACHINES MARKET: KEY CONFERENCES & EVENTS, JANUARY 2024–DECEMBER 2025        90

TABLE 16           NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 92

TABLE 17           EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 93

TABLE 18           ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 94

TABLE 19           REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         95

TABLE 20           PHARMACEUTICAL INSPECTION MACHINES MARKET: PORTER’S FIVE FORCES 97

TABLE 21           INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS             100

TABLE 22           KEY BUYING CRITERIA FOR TOP THREE END USERS IN PHARMACEUTICAL INSPECTION MACHINES MARKET  101

TABLE 23           PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT,

2022–2029 (USD MILLION)          104

TABLE 24           PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          105

TABLE 25           PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY REGION,

2022–2029 (USD MILLION)          105

TABLE 26           NORTH AMERICA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            106

TABLE 27           EUROPE: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          106

TABLE 28           ASIA PACIFIC: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         107

TABLE 29           LATIN AMERICA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         107

TABLE 30           MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            108

TABLE 31           LIST OF KEY VISION INSPECTION SYSTEMS AVAILABLE IN MARKET            109

TABLE 32           VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 110

TABLE 33           VISION INSPECTION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 110

TABLE 34           NORTH AMERICA: VISION INSPECTION SYSTEMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          111

TABLE 35           EUROPE: VISION INSPECTION SYSTEMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          111

TABLE 36           ASIA PACIFIC: VISION INSPECTION SYSTEMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          112

TABLE 37           LATIN AMERICA: VISION INSPECTION SYSTEMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          112

TABLE 38           MIDDLE EAST & AFRICA: VISION INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         113

TABLE 39           MULTIFUNCTIONAL VISION INSPECTION SYSTEMS MARKET, BY REGION,

2022–2029 (USD MILLION)          114

TABLE 40           NORTH AMERICA: MULTIFUNCTIONAL VISION INSPECTION SYSTEMS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            114

TABLE 41           EUROPE: MULTIFUNCTIONAL VISION INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         115

TABLE 42           ASIA PACIFIC: MULTIFUNCTIONAL VISION INSPECTION SYSTEMS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            115

TABLE 43           LATIN AMERICA: MULTIFUNCTIONAL VISION INSPECTION SYSTEMS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            116

TABLE 44           MIDDLE EAST & AFRICA: MULTIFUNCTIONAL VISION INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              116

TABLE 45           SPECIALIZED VISION INSPECTION SYSTEMS MARKET, BY REGION,

2022–2029 (USD MILLION)          117

TABLE 46           NORTH AMERICA: SPECIALIZED VISION INSPECTION SYSTEMS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            117

TABLE 47          EUROPE: SPECIALIZED VISION INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            118

TABLE 48           ASIA PACIFIC: SPECIALIZED VISION INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         118

TABLE 49           LATIN AMERICA: SPECIALIZED VISION INSPECTION SYSTEMS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            119

TABLE 50           MIDDLE EAST & AFRICA: SPECIALIZED VISION INSPECTION SYSTEMS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            119

TABLE 51           LIST OF KEY X-RAY INSPECTION SYSTEMS AVAILABLE IN MARKET            120

TABLE 52           X-RAY INSPECTION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 121

TABLE 53           NORTH AMERICA: X-RAY INSPECTION SYSTEMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          121

TABLE 54           EUROPE: X-RAY INSPECTION SYSTEMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          122

TABLE 55           ASIA PACIFIC: X-RAY INSPECTION SYSTEMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          122

TABLE 56           LATIN AMERICA: X-RAY INSPECTION SYSTEMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          123

TABLE 57           MIDDLE EAST & AFRICA: X-RAY INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         123

TABLE 58           LIST OF KEY LEAK DETECTION SYSTEMS AVAILABLE IN MARKET            124

TABLE 59           LEAK DETECTION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 124

TABLE 60           NORTH AMERICA: LEAK DETECTION SYSTEMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          125

TABLE 61           EUROPE: LEAK DETECTION SYSTEMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          125

TABLE 62           ASIA PACIFIC: LEAK DETECTION SYSTEMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          126

TABLE 63           LATIN AMERICA: LEAK DETECTION SYSTEMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          126

TABLE 64           MIDDLE EAST & AFRICA: LEAK DETECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            127

TABLE 65           LIST OF KEY METAL DETECTORS AVAILABLE IN MARKET              127

TABLE 66           METAL DETECTORS MARKET, BY REGION, 2022–2029 (USD MILLION)          128

TABLE 67          NORTH AMERICA: METAL DETECTORS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          129

TABLE 68           EUROPE: METAL DETECTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     129

TABLE 69           ASIA PACIFIC: METAL DETECTORS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          130

TABLE 70           LATIN AMERICA: METAL DETECTORS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          130

TABLE 71           MIDDLE EAST & AFRICA: METAL DETECTORS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          131

TABLE 72           KEY CHECKWEIGHERS AVAILABLE IN MARKET 132

TABLE 73           CHECKWEIGHERS MARKET, BY REGION, 2022–2029 (USD MILLION)          133

TABLE 74           NORTH AMERICA: CHECKWEIGHERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          133

TABLE 75           EUROPE: CHECKWEIGHERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 134

TABLE 76           ASIA PACIFIC: CHECKWEIGHERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          134

TABLE 77           LATIN AMERICA: CHECKWEIGHERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          135

TABLE 78           MIDDLE EAST & AFRICA: CHECKWEIGHERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          135

TABLE 79           KEY COMBINATION SYSTEMS AVAILABLE IN MARKET  136

TABLE 80           COMBINATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 136

TABLE 81           NORTH AMERICA: COMBINATION SYSTEMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          137

TABLE 82           EUROPE: COMBINATION SYSTEMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          137

TABLE 83           ASIA PACIFIC: COMBINATION SYSTEMS MARKE, BY COUNTRY,

2022–2029 (USD MILLION)          138

TABLE 84           LATIN AMERICA: COMBINATION SYSTEMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          138

TABLE 85           MIDDLE EAST & AFRICA: COMBINATION SYSTEMS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          139

TABLE 86           OTHER PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY REGION,

2022–2029 (USD MILLION)          140

TABLE 87           NORTH AMERICA: OTHER PHARMACEUTICAL INSPECTION SYSTEMS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            140

TABLE 88           EUROPE: OTHER PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         141

TABLE 89           ASIA PACIFIC: OTHER PHARMACEUTICAL INSPECTION SYSTEMS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            141

TABLE 90           LATIN AMERICA: OTHER PHARMACEUTICAL INSPECTION SYSTEMS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            142

TABLE 91           MIDDLE EAST & AFRICA: OTHER PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              142

TABLE 92           KEY PHARMACEUTICAL INSPECTION SOFTWARE AVAILABLE IN MARKET       143

TABLE 93           PHARMACEUTICAL INSPECTION SOFTWARE MARKET, BY REGION,

2022–2029 (USD MILLION)          143

TABLE 94           NORTH AMERICA: PHARMACEUTICAL INSPECTION SOFTWARE MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            144

TABLE 95           EUROPE: PHARMACEUTICAL INSPECTION SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         144

TABLE 96           ASIA PACIFIC: PHARMACEUTICAL INSPECTION SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         145

TABLE 97           LATIN AMERICA: PHARMACEUTICAL INSPECTION SOFTWARE MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            145

TABLE 98           MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION SOFTWARE MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            146

TABLE 99           PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,

2022–2029 (USD MILLION)          148

TABLE 100         FULLY AUTOMATED PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY REGION, 2022–2029 (USD MILLION)  149

TABLE 101         NORTH AMERICA: FULLY AUTOMATED PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              150

TABLE 102         EUROPE: FULLY AUTOMATED PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              150

TABLE 103         ASIA PACIFIC: FULLY AUTOMATED PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              151

TABLE 104         LATIN AMERICA: FULLY AUTOMATED PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              151

TABLE 105         MIDDLE EAST & AFRICA: FULLY AUTOMATED PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 152

TABLE 106         SEMI-AUTOMATED PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY REGION, 2022–2029 (USD MILLION)  153

TABLE 107         NORTH AMERICA: SEMI-AUTOMATED PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              153

TABLE 108         EUROPE: SEMI-AUTOMATED PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)  154

TABLE 109         ASIA PACIFIC: SEMI-AUTOMATED PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              154

TABLE 110         LATIN AMERICA: SEMI-AUTOMATED PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              155

TABLE 111         MIDDLE EAST & AFRICA: SEMI-AUTOMATED PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 155

TABLE 112         MANUAL PHARMACEUTICAL INSPECTION MACHINES MARKET, BY REGION,

2022–2029 (USD MILLION)          156

TABLE 113         NORTH AMERICA: MANUAL PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)  157

TABLE 114         EUROPE: MANUAL PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            157

TABLE 115         ASIA PACIFIC: MANUAL PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            158

TABLE 116         LATIN AMERICA: MANUAL PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            158

TABLE 117         MIDDLE EAST & AFRICA: MANUAL PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)              159

TABLE 118         PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE,

2022–2029 (USD MILLION)          161

TABLE 119         PHARMACEUTICAL INSPECTION MACHINES MARKET FOR AMPOULES & VIALS,

BY REGION, 2022–2029 (USD MILLION)  162

TABLE 120         NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR AMPOULES & VIALS, BY COUNTRY, 2022–2029 (USD MILLION)          163

TABLE 121         EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR AMPOULES & VIALS, BY COUNTRY, 2022–2029 (USD MILLION)              163

TABLE 122         ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR AMPOULES & VIALS, BY COUNTRY, 2022–2029 (USD MILLION)              164

TABLE 123         LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR AMPOULES & VIALS, BY COUNTRY, 2022–2029 (USD MILLION)              164

TABLE 124         MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR AMPOULES & VIALS, BY COUNTRY, 2022–2029 (USD MILLION)          165

TABLE 125         PHARMACEUTICAL INSPECTION MACHINES MARKET FOR SYRINGES, BY REGION, 2022–2029 (USD MILLION)          166

TABLE 126         NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR SYRINGES, BY COUNTRY, 2022–2029 (USD MILLION)              166

TABLE 127         EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR SYRINGES,

BY COUNTRY, 2022–2029 (USD MILLION)            167

TABLE 128         ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR SYRINGES, BY COUNTRY, 2022–2029 (USD MILLION)         167

TABLE 129         LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR SYRINGES, BY COUNTRY, 2022–2029 (USD MILLION)         168

TABLE 130         MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR SYRINGES, BY COUNTRY, 2022–2029 (USD MILLION)              168

TABLE 131         PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BOTTLES, BY REGION, 2022–2029 (USD MILLION)           169

TABLE 132         NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BOTTLES, BY COUNTRY, 2022–2029 (USD MILLION)              169

TABLE 133         EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BOTTLES,

BY COUNTRY, 2022–2029 (USD MILLION)            170

TABLE 134         ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BOTTLES, BY COUNTRY, 2022–2029 (USD MILLION)          170

TABLE 135         LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BOTTLES, BY COUNTRY, 2022–2029 (USD MILLION)          171

TABLE 136         MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BOTTLES, BY COUNTRY, 2022–2029 (USD MILLION)              171

TABLE 137         PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BLISTERS, BY REGION, 2022–2029 (USD MILLION)           172

TABLE 138         NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BLISTERS, BY COUNTRY, 2022–2029 (USD MILLION)              172

TABLE 139         EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BLISTERS,

BY COUNTRY, 2022–2029 (USD MILLION)            173

TABLE 140         ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BLISTERS, BY COUNTRY, 2022–2029 (USD MILLION)          173

TABLE 141         LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BLISTERS, BY COUNTRY, 2022–2029 (USD MILLION)          174

TABLE 142         MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BLISTERS, BY COUNTRY, 2022–2029 (USD MILLION)              174

TABLE 143         PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER PACKAGING TYPES, BY REGION, 2022–2029 (USD MILLION)        175

TABLE 144         NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER PACKAGING TYPES, BY COUNTRY, 2022–2029 (USD MILLION) 175

TABLE 145         EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER PACKAGING TYPES, BY COUNTRY, 2022–2029 (USD MILLION)          176

TABLE 146         ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER PACKAGING TYPES, BY COUNTRY, 2022–2029 (USD MILLION)          176

TABLE 147         LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER PACKAGING TYPES, BY COUNTRY, 2022–2029 (USD MILLION)          177

TABLE 148         MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER PACKAGING TYPES, BY COUNTRY, 2022–2029 (USD MILLION) 177

TABLE 149         PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION,

2022–2029 (USD MILLION)          179

TABLE 150         PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)      180

TABLE 151         PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY REGION, 2022–2029 (USD MILLION) 180

TABLE 152         NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 181

TABLE 153         EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION)              181

TABLE 154         ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION)              182

TABLE 155         LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION)              182

TABLE 156         MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 183

TABLE 157         TABLETS & CAPSULES MARKET, BY REGION, 2022–2029 (USD MILLION)          184

TABLE 158         NORTH AMERICA: TABLETS & CAPSULES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          184

TABLE 159         EUROPE: TABLETS & CAPSULES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          185

TABLE 160         ASIA PACIFIC: TABLETS & CAPSULES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          185

TABLE 161         LATIN AMERICA: TABLETS & CAPSULES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          186

TABLE 162         MIDDLE EAST & AFRICA: TABLETS & CAPSULES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          186

TABLE 163         ORAL SOLUTIONS & SUSPENSIONS/SYRUPS MARKET, BY REGION,

2022–2029 (USD MILLION)          187

TABLE 164         NORTH AMERICA: ORAL SOLUTIONS & SUSPENSIONS/SYRUPS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            187

TABLE 165         EUROPE: ORAL SOLUTIONS & SUSPENSIONS/SYRUPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            188

TABLE 166         ASIA PACIFIC: ORAL SOLUTIONS & SUSPENSIONS/SYRUPS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         188

TABLE 167         LATIN AMERICA: ORAL SOLUTIONS & SUSPENSIONS/SYRUPS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            189

TABLE 168         MIDDLE EAST & AFRICA: ORAL SOLUTIONS & SUSPENSIONS/SYRUPS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            189

TABLE 169         OTHER ORAL FORMULATIONS MARKET, BY REGION, 2022–2029 (USD MILLION)     190

TABLE 170         NORTH AMERICA: OTHER ORAL FORMULATIONS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          190

TABLE 171         EUROPE: OTHER ORAL FORMULATIONS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          191

TABLE 172         ASIA PACIFIC: OTHER ORAL FORMULATIONS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          191

TABLE 173         LATIN AMERICA: OTHER ORAL FORMULATIONS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          192

TABLE 174         MIDDLE EAST & AFRICA: OTHER ORAL FORMULATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         192

TABLE 175         PHARMACEUTICAL INSPECTION MACHINES MARKET FOR PARENTERAL FORMULATIONS, BY REGION, 2022–2029 (USD MILLION) 193

TABLE 176         NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION)     194

TABLE 177         EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION)          194

TABLE 178         ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION)          195

TABLE 179         LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION)          195

TABLE 180         MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION)     196

TABLE 181         PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER FORMULATIONS, BY REGION, 2022–2029 (USD MILLION)            197

TABLE 182         NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 197

TABLE 183         EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION)          198

TABLE 184         ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION)          198

TABLE 185         LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION)          199

TABLE 186         MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 199

TABLE 187         PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER,

2022–2029 (USD MILLION)          201

TABLE 188         PHARMACEUTICAL INSPECTION MACHINES MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2022–2029 (USD MILLION)              202

TABLE 189         NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)     203

TABLE 190         EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)          203

TABLE 191         ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)          204

TABLE 192         LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)          204

TABLE 193         MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)     205

TABLE 194         PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 206

TABLE 195         NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)     206

TABLE 196         EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)          207

TABLE 197         ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)          207

TABLE 198         LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)          208

TABLE 199         MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)     208

TABLE 200         PHARMACEUTICAL INSPECTION MACHINES MARKET FOR CROS & CDMOS,

BY REGION, 2022–2029 (USD MILLION)  209

TABLE 201         NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)          210

TABLE 202         EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)              210

TABLE 203         ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)              211

TABLE 204         LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)              211

TABLE 205         MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR CROS & CDMOS, BY COUNTRY, 2022–2029 (USD MILLION)          212

TABLE 206         PHARMACEUTICAL INSPECTION MACHINES MARKET, BY REGION,

2022–2029 (USD MILLION)          214

TABLE 207         NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            217

TABLE 208         NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY COMPONENT, 2022–2029 (USD MILLION)      217

TABLE 209         NORTH AMERICA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET,

BY TYPE, 2022–2029 (USD MILLION)       218

TABLE 210         NORTH AMERICA: VISION INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          218

TABLE 211         NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       219

TABLE 212         NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY PACKAGING TYPE, 2022–2029 (USD MILLION)            219

TABLE 213         NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY FORMULATION, 2022–2029 (USD MILLION)  220

TABLE 214         NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)          220

TABLE 215         NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY END USER, 2022–2029 (USD MILLION)            221

TABLE 216         US: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT,

2022–2029 (USD MILLION)          222

TABLE 217         US: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          222

TABLE 218         US: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)     223

TABLE 219         US: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,

2022–2029 (USD MILLION)          223

TABLE 220         US: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)    224

TABLE 221         US: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)        224

TABLE 222         US: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)      225

TABLE 223         US: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER,

2022–2029 (USD MILLION)          225

TABLE 224         CANADA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)  226

TABLE 225         CANADA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          227

TABLE 226         CANADA: VISION INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          227

TABLE 227         CANADA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,

2022–2029 (USD MILLION)          228

TABLE 228         CANADA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY PACKAGING TYPE, 2022–2029 (USD MILLION)            228

TABLE 229         CANADA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)             229

TABLE 230         CANADA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)              229

TABLE 231         CANADA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)         230

TABLE 232         EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         231

TABLE 233         EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)  232

TABLE 234         EUROPE: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          232

TABLE 235         EUROPE: VISION INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          233

TABLE 236         EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,

2022–2029 (USD MILLION)          233

TABLE 237         EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY PACKAGING TYPE, 2022–2029 (USD MILLION)            234

TABLE 238         EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)             234

TABLE 239         EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)              235

TABLE 240         EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)         235

TABLE 241         GERMANY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)  236

TABLE 242         GERMANY: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          237

TABLE 243         GERMANY: VISION INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          237

TABLE 244         GERMANY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,

2022–2029 (USD MILLION)          238

TABLE 245         GERMANY: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY PACKAGING TYPE, 2022–2029 (USD MILLION)            238

TABLE 246         GERMANY: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY FORMULATION, 2022–2029 (USD MILLION)  239

TABLE 247         GERMANY: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)              239

TABLE 248         GERMANY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)         240

TABLE 249         UK: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT,

2022–2029 (USD MILLION)          241

TABLE 250         UK: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          241

TABLE 251         UK: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)     242

TABLE 252         UK: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,

2022–2029 (USD MILLION)          242

TABLE 253         UK: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)    243

TABLE 254         UK: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)        243

TABLE 255         UK: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)      244

TABLE 256         UK: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER,

2022–2029 (USD MILLION)          244

TABLE 257         FRANCE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)  245

TABLE 258         FRANCE: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          246

TABLE 259         FRANCE: VISION INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          246

TABLE 260         FRANCE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,

2022–2029 (USD MILLION)          247

TABLE 261         FRANCE: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY PACKAGING TYPE, 2022–2029 (USD MILLION)            247

TABLE 262         FRANCE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)             248

TABLE 263         FRANCE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)              248

TABLE 264         FRANCE: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)         249

TABLE 265         ITALY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)      250

TABLE 266         ITALY: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          250

TABLE 267         ITALY: VISION INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          251

TABLE 268         ITALY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,

2022–2029 (USD MILLION)          251

TABLE 269         ITALY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)            252

TABLE 270         ITALY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)  252

TABLE 271         ITALY: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)            253

TABLE 272         ITALY: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER,

2022–2029 (USD MILLION)          253

TABLE 273         SPAIN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)      254

TABLE 274         SPAIN: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          255

TABLE 275         SPAIN: VISION INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          255

TABLE 276         SPAIN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,

2022–2029 (USD MILLION)          256

TABLE 277         SPAIN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)            256

TABLE 278         SPAIN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)  257

TABLE 279         SPAIN: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)            257

TABLE 280         SPAIN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER,

2022–2029 (USD MILLION)          258

TABLE 281         REST OF EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY COMPONENT, 2022–2029 (USD MILLION)      259

TABLE 282         REST OF EUROPE: PHARMACEUTICAL INSPECTION SYSTEMS MARKET,

BY TYPE, 2022–2029 (USD MILLION)       259

TABLE 283         REST OF EUROPE: VISION INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          260

TABLE 284         REST OF EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       260

TABLE 285         REST OF EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY PACKAGING TYPE, 2022–2029 (USD MILLION)            261

TABLE 286         REST OF EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY FORMULATION, 2022–2029 (USD MILLION)  261

TABLE 287         REST OF EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)              262

TABLE 288         REST OF EUROPE: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY END USER, 2022–2029 (USD MILLION)            262

TABLE 289         ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            265

TABLE 290         ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY COMPONENT, 2022–2029 (USD MILLION)      265

TABLE 291         ASIA PACIFIC: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          266

TABLE 292         ASIA PACIFIC: VISION INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          266

TABLE 293         ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2022–2029 (USD MILLION)    267

TABLE 294         ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY PACKAGING TYPE, 2022–2029 (USD MILLION)            267

TABLE 295         ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY FORMULATION, 2022–2029 (USD MILLION)  268

TABLE 296         ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)              268

TABLE 297         ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)         269

TABLE 298         CHINA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)      270

TABLE 299         CHINA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          270

TABLE 300         CHINA: VISION INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          271

TABLE 301         CHINA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,

2022–2029 (USD MILLION)          271

TABLE 302         CHINA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)            272

TABLE 303         CHINA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)  272

TABLE 304         CHINA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)            273

TABLE 305         CHINA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER,

2022–2029 (USD MILLION)          273

TABLE 306         JAPAN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)      274

TABLE 307         JAPAN: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          275

TABLE 308         JAPAN: VISION INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          275

TABLE 309         JAPAN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,

2022–2029 (USD MILLION)          276

TABLE 310         JAPAN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)            276

TABLE 311         JAPAN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)  277

TABLE 312         JAPAN: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)            277

TABLE 313         JAPAN: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER,

2022–2029 (USD MILLION)          278

TABLE 314         INDIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)      279

TABLE 315         INDIA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          279

TABLE 316         INDIA: VISION INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          280

TABLE 317         INDIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,

2022–2029 (USD MILLION)          280

TABLE 318         INDIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)            281

TABLE 319         INDIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)  281

TABLE 320         INDIA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)            282

TABLE 321         INDIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER,

2022–2029 (USD MILLION)          282

TABLE 322         AUSTRALIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)  283

TABLE 323         AUSTRALIA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          283

TABLE 324         AUSTRALIA: VISION INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          284

TABLE 325         AUSTRALIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,

2022–2029 (USD MILLION)          284

TABLE 326         AUSTRALIA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY PACKAGING TYPE, 2022–2029 (USD MILLION)            285

TABLE 327         AUSTRALIA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY FORMULATION, 2022–2029 (USD MILLION)  285

TABLE 328         AUSTRALIA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)              286

TABLE 329         AUSTRALIA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)         286

TABLE 330         SOUTH KOREA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY COMPONENT, 2022–2029 (USD MILLION)      287

TABLE 331         SOUTH KOREA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)    288

TABLE 332         SOUTH KOREA: VISION INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          288

TABLE 333         SOUTH KOREA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       289

TABLE 334         SOUTH KOREA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY PACKAGING TYPE, 2022–2029 (USD MILLION)            289

TABLE 335         SOUTH KOREA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY FORMULATION, 2022–2029 (USD MILLION)  290

TABLE 336         SOUTH KOREA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)              290

TABLE 337         SOUTH KOREA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY END USER, 2022–2029 (USD MILLION)            291

TABLE 338         REST OF ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY COMPONENT, 2022–2029 (USD MILLION)      292

TABLE 339         REST OF ASIA PACIFIC: PHARMACEUTICAL INSPECTION SYSTEMS MARKET,

BY TYPE, 2022–2029 (USD MILLION)       292

TABLE 340        REST OF ASIA PACIFIC: VISION INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          293

TABLE 341         REST OF ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       293

TABLE 342         REST OF ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY PACKAGING TYPE, 2022–2029 (USD MILLION)            294

TABLE 343         REST OF ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY FORMULATION, 2022–2029 (USD MILLION)  294

TABLE 344         REST OF ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)          295

TABLE 345         REST OF ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY END USER, 2022–2029 (USD MILLION)            295

TABLE 346         LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            296

TABLE 347         LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY COMPONENT, 2022–2029 (USD MILLION)      297

TABLE 348         LATIN AMERICA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)    297

TABLE 349         LATIN AMERICA: VISION INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          298

TABLE 350         LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       298

TABLE 351         LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY PACKAGING TYPE, 2022–2029 (USD MILLION)            299

TABLE 352         LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY FORMULATION, 2022–2029 (USD MILLION)  299

TABLE 353         LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)              300

TABLE 354         LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY END USER, 2022–2029 (USD MILLION)            300

TABLE 355         BRAZIL: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)      301

TABLE 356         BRAZIL: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          302

TABLE 357         BRAZIL: VISION INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          302

TABLE 358         BRAZIL: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,

2022–2029 (USD MILLION)          303

TABLE 359         BRAZIL: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)            303

TABLE 360         BRAZIL: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)  304

TABLE 361         BRAZIL: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)            304

TABLE 362         BRAZIL: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)            305

TABLE 363         MEXICO: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)  306

TABLE 364         MEXICO: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          306

TABLE 365         MEXICO: VISION INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          307

TABLE 366         MEXICO: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,

2022–2029 (USD MILLION)          307

TABLE 367         MEXICO: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY PACKAGING TYPE, 2022–2029 (USD MILLION)            308

TABLE 368         MEXICO: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)             308

TABLE 369         MEXICO: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)              309

TABLE 370         MEXICO: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)         309

TABLE 371         REST OF LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY COMPONENT, 2022–2029 (USD MILLION)      310

TABLE 372         REST OF LATIN AMERICA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET,

BY TYPE, 2022–2029 (USD MILLION)       310

TABLE 373         REST OF LATIN AMERICA: VISION INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          311

TABLE 374         REST OF LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       311

TABLE 375         REST OF LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY PACKAGING TYPE, 2022–2029 (USD MILLION)            312

TABLE 376         REST OF LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY FORMULATION, 2022–2029 (USD MILLION)  312

TABLE 377         REST OF LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)          313

TABLE 378         REST OF LATIN AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY END USER, 2022–2029 (USD MILLION)            313

TABLE 379         MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            314

TABLE 380         MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY COMPONENT, 2022–2029 (USD MILLION)      314

TABLE 381         MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET,

BY TYPE, 2022–2029 (USD MILLION)       315

TABLE 382         MIDDLE EAST & AFRICA: VISION INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          315

TABLE 383         MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       316

TABLE 384         MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY PACKAGING TYPE, 2022–2029 (USD MILLION)            316

TABLE 385         MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY FORMULATION, 2022–2029 (USD MILLION)  317

TABLE 386         MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)          317

TABLE 387         MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY END USER, 2022–2029 (USD MILLION)            318

TABLE 388         GCC COUNTRIES: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY COMPONENT, 2022–2029 (USD MILLION)      319

TABLE 389         GCC COUNTRIES: PHARMACEUTICAL INSPECTION SYSTEMS MARKET,

BY TYPE, 2022–2029 (USD MILLION)       319

TABLE 390         GCC COUNTRIES: VISION INSPECTION SYSTEMS MARKET, BY TYPE,

2022–2029 (USD MILLION)          320

TABLE 391         GCC COUNTRIES: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       320

TABLE 392         GCC COUNTRIES: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY PACKAGING TYPE, 2022–2029 (USD MILLION)            321

TABLE 393         GCC COUNTRIES: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY FORMULATION, 2022–2029 (USD MILLION)  321

TABLE 394         GCC COUNTRIES: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)              322

TABLE 395         GCC COUNTRIES: PHARMACEUTICAL INSPECTION MACHINES MARKET,

BY END USER, 2022–2029 (USD MILLION)            322

TABLE 396         REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT, 2022–2029 (USD MILLION)              323

TABLE 397         REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)     323

TABLE 398         REST OF MIDDLE EAST & AFRICA: VISION INSPECTION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 324

TABLE 399         REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE, 2022–2029 (USD MILLION) 324

TABLE 400         REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE, 2022–2029 (USD MILLION)          325

TABLE 401         REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION, 2022–2029 (USD MILLION)          325

TABLE 402         REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET FOR ORAL FORMULATIONS, BY TYPE, 2022–2029 (USD MILLION)     326

TABLE 403         REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER, 2022–2029 (USD MILLION)              326

TABLE 404         OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS              327

TABLE 405         PHARMACEUTICAL INSPECTION MACHINES MARKET: DEGREE OF COMPETITION       331

TABLE 406         PHARMACEUTICAL INSPECTION MACHINES MARKET: COMPONENT FOOTPRINT        335

TABLE 407         PHARMACEUTICAL INSPECTION MACHINES MARKET: TYPE FOOTPRINT      336

TABLE 408         PHARMACEUTICAL INSPECTION MACHINES MARKET: PACKAGING TYPE FOOTPRINT 337

TABLE 409         PHARMACEUTICAL INSPECTION MACHINES MARKET: REGION FOOTPRINT    338

TABLE 410         PHARMACEUTICAL INSPECTION MACHINES MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS            341

TABLE 411         PHARMACEUTICAL INSPECTION MACHINES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES         342

TABLE 412         PHARMACEUTICAL INSPECTION MACHINES MARKET: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024             345

TABLE 413         PHARMACEUTICAL INSPECTION MACHINES MARKET: DEALS,

JANUARY 2021–MAY 2024            346

TABLE 414         PHARMACEUTICAL INSPECTION MACHINES MARKET: EXPANSIONS,

JANUARY 2021–MAY 2024            347

TABLE 415         KÖRBER AG: COMPANY OVERVIEW       348

TABLE 416         KÖRBER AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED              349

TABLE 417         KÖRBER AG: DEALS, JANUARY 2021–MAY 2024   352

TABLE 418         METTLER TOLEDO: COMPANY OVERVIEW        353

TABLE 419         METTLER TOLEDO: PRODUCTS/SERVICES/SOLUTIONS OFFERED          354

TABLE 420         METTLER TOLEDO: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024           358

TABLE 421         METTLER TOLEDO: EXPANSIONS, JANUARY 2021–MAY 2024              359

TABLE 422         OMRON CORPORATION: COMPANY OVERVIEW             360

TABLE 423         OMRON CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED          361

TABLE 424         COGNEX CORPORATION: COMPANY OVERVIEW            363

TABLE 425         COGNEX CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED          364

TABLE 426         COGNEX CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024 367

TABLE 427         COGNEX CORPORATION: DEALS, JANUARY 2021–MAY 2024              367

TABLE 428         STEVANATO GROUP: COMPANY OVERVIEW     369

TABLE 429         STEVANATO GROUP: PRODUCTS/SERVICES/SOLUTIONS OFFERED          370

TABLE 430         STEVANATO GROUP: PRODUCT LAUNCHES, JANUARY 2021–MAY 2024           372

TABLE 431         ANTARES VISION S.P.A: COMPANY OVERVIEW  373

TABLE 432         ANTARES VISION S.P.A: PRODUCTS/SERVICES/SOLUTIONS OFFERED          374

TABLE 433         ANTARES VISION S.P.A: DEALS, JANUARY 2021–MAY 2024              377

TABLE 434         OPTEL GROUP: COMPANY OVERVIEW  378

TABLE 435         OPTEL GROUP: PRODUCTS/SERVICES/SOLUTIONS OFFERED              378

TABLE 436         SYNTEGON TECHNOLOGY GMBH: COMPANY OVERVIEW              380

TABLE 437         SYNTEGON TECHNOLOGY GMBH: PRODUCTS/SERVICES/SOLUTIONS OFFERED   381

TABLE 438         SYNTEGON TECHNOLOGY GMBH: PRODUCT LAUNCHES,

JANUARY 2021–MAY 2024            383

TABLE 439         JEKSON VISION: COMPANY OVERVIEW 384

TABLE 440         JEKSON VISION: PRODUCTS/SERVICES/SOLUTIONS OFFERED              384

TABLE 441         ACG: COMPANY OVERVIEW      386

TABLE 442         ACG: PRODUCTS/SERVICES/SOLUTIONS OFFERED       386

TABLE 443         BREVETTI CEA SPA: COMPANY OVERVIEW        389

TABLE 444         BREVETTI CEA SPA: PRODUCTS/SERVICES/SOLUTIONS OFFERED          389

TABLE 445         BREVETTI CEA SPA: DEALS, JANUARY 2021–MAY 2024    392

TABLE 446         ROQUETTE FRÈRES: COMPANY OVERVIEW       393

TABLE 447         ROQUETTE FRÈRES: PRODUCTS/SERVICES/SOLUTIONS OFFERED          393

TABLE 448         TOFFLON LIFE SCIENCE: COMPANY OVERVIEW             395

TABLE 449         TOFFLON LIFE SCIENCE: PRODUCTS/SERVICES/SOLUTIONS OFFERED          395

TABLE 450         PRODITEC: COMPANY OVERVIEW         397

TABLE 451         PRODITEC: PRODUCTS/SERVICES/SOLUTIONS OFFERED              397

TABLE 452         WIPOTEC GMBH: COMPANY OVERVIEW            399

TABLE 453         WIPOTEC GMBH: PRODUCTS/SERVICES/SOLUTIONS OFFERED          399

TABLE 454         CMP PHARMA S.R.L.: COMPANY OVERVIEW       401

TABLE 455         CMP PHARMA S.R.L.: PRODUCTS/SERVICES/SOLUTIONS OFFERED          401

TABLE 456         CMP PHARMA S.R.L.: EXPANSIONS, JANUARY 2021–MAY 2024              403

TABLE 457         KEYENCE CORPORATION: COMPANY OVERVIEW           404

TABLE 458         CASSEL MESSTECHNIK GMBH: COMPANY OVERVIEW   405

TABLE 459         THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW              406

TABLE 460         LOMA SYSTEMS: COMPANY OVERVIEW 407

TABLE 461         VITRONIC DR.-ING. STEIN BILDVERARBEITUNGSSYSTEME GMBH:

COMPANY OVERVIEW  408

TABLE 462         MINEBEA INTEC GMBH: COMPANY OVERVIEW 409

TABLE 463         MARCHESINI GROUP S.P.A.: COMPANY OVERVIEW        410

TABLE 464         N.K.P. PHARMA PVT. LTD.: COMPANY OVERVIEW          411

TABLE 465         SPAN SYSTEMS: COMPANY OVERVIEW 411

LIST OF FIGURES

FIGURE 1           PHARMACEUTICAL INSPECTION MACHINES MARKET: SEGMENTS COVERED   37

FIGURE 2           PHARMACEUTICAL INSPECTION MACHINES MARKET: REGIONS COVERED      38

FIGURE 3           PHARMACEUTICAL INSPECTION MACHINES MARKET: YEARS CONSIDERED   38

FIGURE 4           PHARMACEUTICAL INSPECTION MACHINES MARKET: RESEARCH DESIGN       41

FIGURE 5           BREAKDOWN OF PRIMARIES (SUPPLY- AND DEMAND-SIDE PARTICIPANTS)             43

FIGURE 6           MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS (2023)              44

FIGURE 7           MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (2023)       45

FIGURE 8           FIGURE 5 ILLUSTRATIVE EXAMPLE OF KÖRBER AG: REVENUE SHARE ANALYSIS (2023) 45

FIGURE 9           MARKET VALIDATION FROM PRIMARY SOURCES           47

FIGURE 10         MARKET SIZE ESTIMATION: TOP-DOWN APPROACH    48

FIGURE 11         PHARMACEUTICAL INSPECTION MACHINES MARKET: CAGR PROJECTIONS

(2024–2029)       49

FIGURE 12         DATA TRIANGULATION             52

FIGURE 13         PHARMACEUTICAL INSPECTION MACHINES MARKET, BY COMPONENT,

2024 VS. 2029 (USD MILLION)     55

FIGURE 14         PHARMACEUTICAL INSPECTION SYSTEMS MARKET, BY TYPE,

2024 VS. 2029 (USD MILLION)     56

FIGURE 15         PHARMACEUTICAL INSPECTION MACHINES MARKET, BY TYPE,

2024 VS. 2029 (USD MILLION)     57

FIGURE 16         PHARMACEUTICAL INSPECTION MACHINES MARKET, BY PACKAGING TYPE,

2024 VS. 2029 (USD MILLION)     57

FIGURE 17         PHARMACEUTICAL INSPECTION MACHINES MARKET, BY FORMULATION,

2024 VS. 2029 (USD MILLION)     58

FIGURE 18         PHARMACEUTICAL INSPECTION MACHINES MARKET, BY END USER,

2024 VS. 2029 (USD MILLION)     59

FIGURE 19         PHARMACEUTICAL INSPECTION MACHINES MARKET: REGIONAL SNAPSHOT 60

FIGURE 20         STRINGENT INSPECTION CHECKPOINT MANDATES AND FAVORABLE REGULATORY POLICIES TO DRIVE MARKET           61

FIGURE 21         US AND AMPOULES & VIALS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023          62

FIGURE 22         PHARMACEUTICAL INSPECTION SYSTEMS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD         63

FIGURE 23         ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATES DURING STUDY PERIOD              64

FIGURE 24         PHARMACEUTICAL INSPECTION MACHINES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    65

FIGURE 25         REVENUE SHIFT TOWARD KEY PLAYERS IN PHARMACEUTICAL INSPECTION MACHINES MARKET          72

FIGURE 26         AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL INSPECTION MACHINES, BY REGION (USD THOUSAND)            76

FIGURE 27         PHARMACEUTICAL INSPECTION MACHINES MARKET: VALUE CHAIN ANALYSIS           77

FIGURE 28         PHARMACEUTICAL INSPECTION MACHINES MARKET: SUPPLY CHAIN ANALYSIS           78

FIGURE 29         PHARMACEUTICAL INSPECTION MACHINES MARKET: ECOSYSTEM MAP          81

FIGURE 30         NUMBER OF PATENTS GRANTED ANNUALLY, 2014–2024              84

FIGURE 31         TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS,

2014–2024          85

FIGURE 32         REGIONAL ANALYSIS OF PATENTS GRANTED, 2014–2024              85

FIGURE 33         PHARMACEUTICAL INSPECTION MACHINES MARKET: PORTER’S FIVE FORCES 97

FIGURE 34         KEY STAKEHOLDERS IN BUYING PROCESS         99

FIGURE 35         KEY BUYING CRITERIA FOR TOP THREE END USERS      100

FIGURE 36         NORTH AMERICA: PHARMACEUTICAL INSPECTION MACHINES MARKET SNAPSHOT             216

FIGURE 37         ASIA PACIFIC: PHARMACEUTICAL INSPECTION MACHINES MARKET SNAPSHOT     264

FIGURE 38         REVENUE ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL INSPECTION MACHINES MARKET (2021–2023)   329

FIGURE 39         MARKET SHARE ANALYSIS OF KEY PLAYERS IN PHARMACEUTICAL INSPECTION MACHINES MARKET (2023)     330

FIGURE 40         PHARMACEUTICAL INSPECTION MACHINES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 333

FIGURE 41         PHARMACEUTICAL INSPECTION MACHINES MARKET: COMPANY FOOTPRINT 334

FIGURE 42         PHARMACEUTICAL INSPECTION MACHINES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023        340

FIGURE 43         EV/EBITDA OF KEY PLAYERS    342

FIGURE 44         YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK

BETA OF KEY PLAYERS 343

FIGURE 45         PHARMACEUTICAL INSPECTION MACHINES MARKET:

BRAND/PRODUCT COMPARATIVE ANALYSIS    344

FIGURE 46         KÖRBER AG: COMPANY SNAPSHOT (2023)         349

FIGURE 47         METTLER TOLEDO: COMPANY SNAPSHOT (2023)          354

FIGURE 48         OMRON CORPORATION: COMPANY SNAPSHOT (2023) 361

FIGURE 49         COGNEX CORPORATION: COMPANY SNAPSHOT (2023) 364

FIGURE 50         STEVANATO GROUP: COMPANY SNAPSHOT (2023)       370

FIGURE 51         ANTARES VISION S.P.A: COMPANY SNAPSHOT (2023)    374